Clinical Trial Update: Pilot Study of Hepatitis C Virus Entry Inhibitor (ITX 5061) in Liver Transplant Recipients [Phase 1]

View source ↗

Summary

Phase 1 pilot study of the hepatitis C virus entry inhibitor ITX 5061 in liver transplant recipients has completed. The update summarizes the results from this …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• ITX 5061 (ITX-5061)

Snippet

Sponsor: University of Birmingham | Conditions: Hepatitis C, Evidence of Liver Transplantation | Phase 1 | Status: COMPLETED